CoChat

A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma

Open access

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 10 of the 21 sources its claims cite were checked for support.

Abstract

Objectives: Evidence for the efficacy of Cognitive Behavioural Therapy (CBT) in asthma is developing but it is not known if this translates to benefits in severe asthma or if a group approach is acceptable to this patient group. This study aimed to assess the feasibility and acceptability of Group-CBT in severe asthma. Method: This was a two-centre, randomised controlled parallel group feasibility study. Eligible participants (patients with severe asthma and a clinically significant diagnosis of anxiety and/or depression–Hospital Anxiety and Depression Scale (HAD) score greater than 8 for the anxiety or depression sub-scale) received Group-CBT in weekly sessions for eight consecutive weeks and usual care or usual care only. Follow-up was for 16 weeks and end points were: Asthma Quality of Life Questionnaire, Asthma Control Questionnaire, HAD, Dyspnoea-12, EuroQual-5D and EuroQuol-VAS. Results: 51 patients were randomised: 36% (51 out of 140) consent rate and attrition at week 16 was 12. Screening logs indicated that study take-up was influenced by patients living long distances from the treatment centre and inability to commit to the weekly demands of the programme. Drop-out was higher in Group-CBT compared due to inability to commit to the weekly programme because of poor health. Participants who contributed to focus group discussions reported that Group-CBT contributed to a better understanding of their illness and related approaches to anxiety management and acceptance of their asthma condition. Although weekly face-to-face sessions were challenging, this was the preferred method of delivery for these participants. Conclusions: This feasibility study shows that Group-CBT warrants further investigation as a potentially promising treatment option for patients with severe asthma. It has been possible but not easy to recruit and retain the sample. Options for a less demanding intervention schedule, such as less frequent face-to-face visits and the use of web-based interventions, require careful consideration. © 2017 Taylor & Francis Group, LLC.

Overview

CoChat Summary

TL;DR

This two-centre randomised feasibility trial found that Group-CBT for people with severe asthma and clinically significant anxiety/depression was acceptable to some completers, but recruitment and retention were challenging. It supports further investigation, with Dyspnoea-12 identified as a promising endpoint for a fully powered trial.

Key findings

  • Of 140 eligible patients approached, 51 (36%) consented and were randomised; attrition at week 16 was 12 (G-CBT n = 10, control n = 2), and after removing 7 protocol deviations, 44 remained for analysis. The paper also reports 73% (32/44) retained at week 16, giving a 27% attrition rate.
  • Recruitment barriers were travel concerns in 35% of those approached (n = 32; 30 from the London site), family commitments in 24 (27%), and work commitments in 19 (21%).
  • Of 23 eligible participants who commenced G-CBT, 4 attended all eight sessions and 8 attended five to seven sessions; the main reason for missing sessions was being too unwell with asthma to travel or participate.
  • At week 16, Dyspnoea-12 total mean change was −5.5 (SD 6.6) for G-CBT versus −0.1 (SD 10.0) for control, with an effect size of 0.62 (p = 0.093); Dyspnoea-12 Physical had an effect size of 0.66 (p = 0.045). An MCID for Dyspnoea-12 of 3.5 was justified, and 74 per arm gave 80% power, adjusted to 91/arm (182 total) for attrition. Qualitative participants valued the group format and preferred face-to-face sessions over telephone, web-based, or Skype delivery.

Methods

  • Two-centre, randomised controlled parallel group feasibility trial comparing usual care plus Group-CBT (weekly 1.5-hour sessions for 8 consecutive weeks) with usual care only; follow-up was 16 weeks.
  • Participants were adults ≥18 years with confirmed severe refractory asthma receiving BTS Steps 4 and 5 care and HADS score >8 for anxiety or depression; those with specific psychiatric conditions were excluded. 140 patients were approached and 51 were randomised 1:1.
  • Outcomes included AQLQ, ACQ, HAD, Dyspnoea-12, EQ-5D/VAS, and an asthma diary; focus groups and one-to-one interviews explored acceptability. Analysis used paired differences compared between groups with independent t-tests, effect sizes, MCID and sample-size calculations, and thematic qualitative analysis.

Limitations

  • Stated: access was limited to two UK specialist clinics, limiting generalizability; focus groups/interviews included only active participants, not those who declined or dropped out, due to ethical restrictions; the study did not control for attention; and it was small, underpowered, and not designed to test effectiveness.
  • Stated/evident: G-CBT had higher attrition and variable attendance, and asthma diary completion was insufficient for meaningful comparisons (14 participants completed diaries). Seven protocol deviations occurred because ineligible patients with HADS ≤8 were entered and later removed, and RN blinding was difficult to maintain.
  • Evident: no formal sample-size calculation was performed, no adjustment for multiple comparisons was made, and qualitative views may overrepresent participants who accepted and valued face-to-face group therapy.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/02770903.2016.1229335

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

5 Valid · 5 Not valid · 5 Not checked · 80 Own results and interpretations

28 more claims

Create a free account to see all 95 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 38
  • It may state two separate claims as one. 35
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

4 of 4

Citations

Cites

Show all 32 references

Research works printed but not linked: 9

  1. Schneider A, Respir Med., 102, 566
  2. Roth A, Fonagy P. What works for whom: A critical review of psychotherapy research. Second Edition. London: The Guildford Press; 2005.
  3. National Institute for Clinical Excellence, Manchester, UK: National Institute for Clinical Excellence Guidelines
  4. O'Dowd H, Health Technol Assess, 10
  5. American Thoracic Society, Am J Respir Acute Crit Care Med., 162, 2341
  6. British Thoracic Society Scottish Intercollegiate Guidelines Network, Thorax, 63, 1e121
  7. Antoni MH, Stress management for persons with HIV infection
  8. Whitehead AL, Stat Methods Med Res.
  9. IBM Corporation, IBM SPSS Statistics for Windows, Version 22.0

Cited by

See all 34

Metadata

Authors
Yorke, J., Adair, P., Doyle, A.-M., Dubrow-Marshall, L., Fleming, S., Holmes, L., Menzies-Gow, A., Niven, R., Pilling, M., & Shuldham, C.
Affiliations
  • University of Manchester (GB)
  • University of Strathclyde (GB)
  • Royal Brompton & Harefield NHS Foundation Trust (GB)
  • Department of Applied Psychology, Therapies, University of Salford, Salford, UK
  • North West Lung Centre University Hospital South Manchester, Manchester, UK
Corresponding author
Yorke, Janelle
Venue
Journal of Asthma
Published
2016-11-23
Volume
54
Issue
5
Pages
543-554
ISSN
  • 0277-0903 (ISSN-L)
  • 1532-4303
OpenAlex
W2526096696
Cited by
34
References
31
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 2 · 2016: 1
FWCI
3.22
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Journal of Asthma (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (publishedVersion, other-oa)
  • Research Explorer (The University of Manchester) (submittedVersion, other-oa)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (submittedVersion)
  • University of Salford Institutional Repository (University of Salford) (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
group cognitive behavioral therapy, severe asthma, anxiety, depression, feasibility, acceptability, asthma quality of life, asthma control, medication adherence, recruitment and retention, online intervention
MeSH terms
Adult, Aged, Anxiety, Asthma, Depression, Dyspnea, Female, Humans, Male, Middle Aged, Psychotherapy, Group, Quality of Life, Severity of Illness Index, Stress, Psychological, Cognitive Behavioral Therapy, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma. https://app.cochat.ai/papers/10.1080/02770903.2016.1229335
The paper
Yorke, J., Adair, P., Doyle, A.-M., Dubrow-Marshall, L., Fleming, S., Holmes, L., Menzies-Gow, A., Niven, R., Pilling, M., & Shuldham, C. (2017). A randomised controlled feasibility trial of Group Cognitive Behavioural Therapy for people with severe asthma. Journal of Asthma. https://doi.org/10.1080/02770903.2016.1229335

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.